Allergy Therapeutics is a Europe-based specialty pharmaceutical company focused upon the diagnosis and treatment of allergy. Allergy Therapeutics has an existing sales base of approximately £70 million per annum, an MHRA-approved manufacturing capability, as well as an established sales and marketing infrastructure in major European markets. In addition, the Company has a number of novel compounds which have already undergone initial clinical evaluation and, once registered, could potentially revolutionise the treatment of allergy.
Market: London Full List
Lead analyst: Dr Martin Hall
If you'd like to be introduced to the team at Allergy Therapeutics plc, get in touch.Request a meeting